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Transmissible spongiform encephalopathies 
(TSEs) are fatal neurodegenerative disorders af-
flicting many mammals (Aguzzi, 2006). Prions, 
the infectious particles that cause TSEs, consist 
mostly of PrPSc, a -sheet–rich higher-order ag-
gregate of the membrane protein PrPC (Prusiner, 
1982). TSE-affected brains display neuronal 
vacuolation and loss, microglial activation, astro-
gliosis, and deposition of PrPSc (Prusiner et al., 
1983; Weissmann, 2004).
The molecular mechanisms underlying brain 
damage in prion diseases are not well under-
stood. Grafting experiments of wild-type brain 
tissue into PrPC-deficient brains showed that 
the neuropathological changes only occurred 
in tissue expressing PrPC, even if proteinase K 
(PK)–resistant PrPSc was also detected in the 
surrounding Prnpo/o tissue (Brandner et al., 1996). 
These results indicate that neurotoxicity depends 
on PrPC expression by the target cells, whereas 
PrPSc does not appear to be intrinsically toxic. 
This notion was confirmed by neuron-specific 
ablation of Prnp (Mallucci et al., 2003) and in 
mice expressing anchorless PrP, which is con-
verted into a protease-resistant isoform and 
forms amyloid plaques yet causes minimal neu-
ronal damage (Chesebro et al., 2005).
Prion diseases exhibit frequent neuronal 
apoptosis (Liberski et al., 2004). Although inhi-
bition of apoptosis by overexpressing Bcl-2 or 
ablating Bax did not affect the life expectancy 
of prion-inoculated mice (Steele et al., 2007), 
prion-infected brain cells may release membrane 
fragments even when undergoing nonapoptotic 
death. Furthermore, exosomes may be released 
by perfectly healthy cells (Théry et al., 2009) and 
may conceivably carry prion infectivity.
A trait common to each of these extracellular 
vesicles is the surface exposure of phosphatidyl 
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Progressive accumulation of PrPSc, a hallmark of prion diseases, occurs when conversion of 
PrPC into PrPSc is faster than PrPSc clearance. Engulfment of apoptotic bodies by phagocytes 
is mediated by Mfge8 (milk fat globule epidermal growth factor 8). In this study, we show 
that brain Mfge8 is primarily produced by astrocytes. Mfge8 ablation induced accelerated 
prion disease and reduced clearance of cerebellar apoptotic bodies in vivo, as well as exces-
sive PrPSc accumulation and increased prion titers in prion-infected C57BL/6 × 129Sv mice 
and organotypic cerebellar slices derived therefrom. These phenotypes correlated with the 
presence of 129Sv genomic markers in hybrid mice and were not observed in inbred 
C57BL/6 Mfge8/ mice, suggesting the existence of additional strain-specific genetic 
modifiers. Because Mfge8 receptors are expressed by microglia and depletion of microglia 
increases PrPSc accumulation in organotypic cerebellar slices, we conclude that engulfment 
of apoptotic bodies by microglia may be an important pathway of prion clearance con-
trolled by astrocyte-borne Mfge8.
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production or through reduced degradation. This possibility 
was studied with four methodologies: qualitative assessment of 
PrP immunoreactivity in histological sections of terminally 
diseased brains (Fig. 1 B), quantitation of PrPSc chemilumi-
nescence in Western blots of brain homogenates (Fig. 1 C), 
quantitation of aggregated PrP (PrPMPA) by the misfolded pro-
tein assay (MPA; Fig. 1 D; Lau et al., 2007), and infectivity 
titer determinations with the scrapie cell assay (SCA; Fig. S1 C). 
The MPA captures misfolded and aggregated proteins by 
precipitation with peptoid-coated magnetic beads; captured 
proteins are then disaggregated and quantitated by sandwich 
ELISA with anti-PrP antibodies (Polymenidou et al., 2008).
PrP immunoreactivity was much more intense in prion-
infected Mfge8/ brains than in Mfge8+/+ control brains 
(Fig. 1 B). Also, brains of terminally scrapie-sick Mfge8/ 
mice displayed increased PK-resistant PrPSc and PrPMPA  
(P < 0.03 and P < 0.034, respectively; Fig. 1, C and D). This is 
noteworthy because Mfge8/ mice attained terminal scrapie 
already at 160 d postinoculation (dpi), i.e., 40 d earlier than 
Mfge8+/+ mice. Because brain PrPSc accumulates exponen-
tially over time, shorter incubation times typically go along 
with reduced PrPSc deposition and vice versa (Büeler et al., 
1994). Therefore, we analyzed brain homogenates of pre-
clinical Mfge8+/+ and Mfge8/ mice sacrificed at 120 dpi by 
MPA. Already at this early time point, a tendency toward 
higher PrPSc levels was detected in Mfge8/ brains, support-
ing the idea of accelerated PrPSc deposition (Fig. 1 D). PrPC 
concentrations, as measured by ELISA, did not differ be-
tween noninfected Mfge8+/+ and Mfge8/ brain homoge-
nates (Fig. S1 B), confirming that the increase in PrPSc was 
not caused by altered PrPC expression in Mfge8/ mice.
Next, we asked whether the increased PrPSc deposition 
would lead to increased infectivity titers in Mfge8/ brains. 
We compared brain homogenates from Mfge8+/+ and Mfge8/ 
mice at terminal disease stage by SCA using the prion-susceptible 
neuroblastoma cell line PK1 (Klöhn et al., 2003). We ob-
served a slight trend toward increased infectivity in Mfge8/ 
brains (7.48 ± 0.07 TCI [infectious tissue culture] units and 
7.30 ± 0.12 TCI units in Mfge8+/+ and Mfge8/ brains, re-
spectively), which, however, did not attain statistical signifi-
cance (Fig. S1 C).
We also assessed PrPSc accumulation ex vivo using the 
prion organotypic slice culture assay (Falsig et al., 2008). 
Cerebellar Mfge8+/+ and Mfge8/ slices were infected with 
3,000 LD50 units of RML6 prions and harvested after 5 wk. 
Western blot analysis showed significantly higher (P < 0.024) 
PrPSc levels in Mfge8/ brain slices (Fig. 1 E), confirming 
that increased prion accumulation in Mfge8/ mice was en-
tirely independent of any indirect effects caused by Mfge8 
deficiency in extraneural compartments.
Next, we analyzed whether accelerated disease progres-
sion occurred concomitantly with additional pathological 
changes. The severity of astrogliosis, microgliosis (Fig. 2, 
A and B), and spongiosis (Fig. S1 D) at terminal disease was 
analyzed immunohistochemically. All of these parameters 
were similar in Mfge8+/+ and Mfge8/ brains. Thus, the brain 
serine (PS), which can be recognized by the secreted ligand, 
Mfge8 (milk fat globule epidermal growth factor 8; Patton 
and Keenan, 1975). By virtue of its affinity to PS, Mfge8 
helps mediating the removal of apoptotic bodies (Hanayama 
et al., 2002). Phagocytic cells then bind Mfge8-opsonized 
apoptotic cells through v3 and v5 integrins. Mfge8 
is secreted by some phagocytic cells, including immature 
DCs and thioglycolate-activated peritoneal macrophages, as 
well as nonhematopoietic cells, including mammary epithe-
lial cells (Hanayama and Nagata, 2005) and follicular DCs 
(FDCs; Kranich et al., 2008). A recent study described a 
potential involvement of Mfge8 expressed by human astro-
cytes, microglia, and smooth muscle cells in the removal of 
A plaques (Boddaert et al., 2007). A microarray screen also 
identified Mfge8 expression in mouse astrocytes (Cahoy 
et al., 2008). Another study claimed Mfge8 expression 
in vitro by the microglial cell line BV-2 (Fuller and Van 
Eldik, 2008).
In this study, we show by in situ RNA hybridization (ISH) 
and quantitative RT-PCR that Mfge8 is primarily expressed 
by subsets of astrocytes in the central nervous system (CNS). 
Furthermore, Mfge8 deficiency resulted in accelerated prion 
pathogenesis and enhanced PrPSc accumulation in the CNS 
and was accompanied by elevated numbers of apoptotic cere-
bellar granule cells. These results suggest that Mfge8 is required 
for the efficient removal of apoptotic cells in the CNS and 
possibly also for degradation of prions.
RESULTS
Mfge8-deficient mice show accelerated prion pathogenesis
We inoculated Mfge8/ mice (bred as intercrosses of the 
C57BL/6 and 129Sv mouse strains) i.c. (intracerebrally) or i.p. 
with RML6 (Rocky Mountain Laboratory strain, passage 6) 
prions (1,000 LD50 units). We monitored the mice for clini-
cal signs of scrapie and defined the incubation period as the 
time until mice reached the terminal stage of disease. Mfge8/ 
mice succumbed to scrapie much earlier than Mfge8+/+ mice. 
This acceleration was more pronounced after i.c. inoculation 
(40 d; Fig. 1 A, left) than after i.p. inoculation (20 d, 
Fig. 1 A, right), suggesting that it was caused by the 
absence of Mfge8 within the CNS rather than in extra-
neural compartments.
Because Mfge8 is highly expressed by FDCs (Kranich et al., 
2008), which are important sites of extraneural prion replica-
tion (Aguzzi and Heikenwalder, 2005), we probed the splenic 
PrPSc content on PK-treated histoblots. Follicular PrPSc  
accumulation was similar in Mfge8+/+ and Mfge8/ spleens 
(Fig. S1 A). Along with the accelerated pathogenesis of i.c. in-
oculated mice, this finding makes it unlikely that extraneural 
prion-modulating events caused the acceleration in Mfge8/ 
mice. Therefore, we focused all further analyses on the inter-
play between Mfge8 and prions within the CNS.
Mfge8-deficient mice exhibit elevated levels of PrPSc
We reasoned that accelerated disease progression may result 
from enhanced accumulation of PrPSc, be it through increased 
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Figure 1. Mfge8/ mice show accelerated disease progression. (A) B6.129-Mfge8/, B6.129-Mfge8/+, and B6.129-Mfge8+/+ were inoculated i.c. 
with 3 log LD50 (n = 10 for Mfge8/, n = 4 for Mfge8+/, and n = 11 for Mfge8+/+) and i.p. with 3 log LD50 per group of RML6 prions. The mean incuba-
tion time after i.c. inoculation was significantly accelerated in Mfge8/ mice (159 ± 2 d in Mfge8/, 179 ± 3 d in Mfge8+/, and 202 ± 3.9 d in Mfge8+/+ 
mice; P < 0.0001, logrank). Differences in incubation time after i.p. inoculation were less pronounced (206 ± 6 d in Mfge8/ and 229 ± 10 d in Mfge8+/+ 
mice) but still significant (P = 0.004, logrank test). (B) Stainings of brain sections after 30 dpi (left) or at terminal stage (right) using anti-PrP antibody 
SAF84. Bars, 1 mm. (C) Western blot of PK-digested brain homogenates from i.c. inoculated Mfge8+/+ and Mfge8/ mice using anti-PrP antibody POM1 
(C, uninoculated brain homogenate). Western blot for actin on non-PK–digested sample is shown below. Densitometric quantitation of POM1 signal nor-
malized over actin expression. Bar graph shows mean relative signal intensity (n = 4; *, P = 0.03; Student’s t test). (D) MPA of brain homogenates from 
Mfge8+/+ and Mfge8/ mice at 120 dpi or at terminal disease (n = 6–7 mice per group; *, P = 0.034; Student’s t test) indicated in percentages of RML6 
prion–inoculated brain homogenate. Mfge8/ mice sacrificed at 120 dpi showed a slight increase over Mfge8+/+ mice. (E) Mfge8+/+ and Mfge8/ 
cerebellar slices were inoculated with 3 × 3 log LD50 RML6 prions or with noninfectious brain homogenate (mock), harvested after 5 wk, homogenized, 
and PK digested (C, brain homogenate from a terminal RML inoculated mouse used as positive control). PrPSc levels were analyzed by Western blotting 
using POM1 and normalized against actin (without PK digestion) by densitometry (bar graph; n = 4; *, P = 0.024; Student’s t test). Error bars represent SD. 
Histology, Western blot, and MPA results represent at least four independent experiments.
pathology of terminally scrapie-sick Mfge8/ mice was as 
strong as in Mfge8+/+ mice, although terminal disease was 
reached 40 d earlier. We conclude that the processes leading 
to brain damage were also accelerated.
Increased prevalence of apoptotic cells in the cerebellum  
of Mfge8/ mice
Beyond accelerated prion disease, Mfge8/ mice have no obvi-
ous CNS defects. However, prion infections lead to significant 
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2008) were reported to produce Mfge8, suggesting that mi-
croglia in vivo may also be a source of Mfge8. As we did not 
detect Mfge8 in the CNS by immunohistochemistry using 
anti-Mfge8 antibodies (unpublished data), we focused on 
RNA expression analysis as a more reliable tool for detecting 
the source of secreted proteins such as Mfge8. We performed 
ISHs using an Mfge8 RNA probe and found Mfge8 transcrip-
tion in the cerebellum at the watershed between internal 
granular and molecular layers. Mfge8-expressing cells lacked 
the characteristic morphology of Purkinje neurons. In view 
of their localization and morphology, Bergman glia (a spe-
cialized type of astrocytes) were deemed the most likely 
source of Mfge8 (Fig. 3 A, top). We also found cortical 
Mfge8-expressing cells with a stellate appearance indicative of 
astrocytes (Fig. 3 A, bottom). To validate the presumption 
that Mfge8 is expressed by astrocytes, we quantified Mfge8 
messenger RNA (mRNA) expression by quantitative RT-PCR 
on cultured CNS cells enriched for distinct subpopulations. 
We found sustained Mfge8 expression in cultures enriched for 
astrocytes (purity of the astrocyte population, >95%; unpub-
lished data) but little Mfge8 mRNA in cultures enriched for 
oligodendrocytes (purity, 85%) or for cerebellar granule neu-
rons (purity, 95%). Conversely, we detected only minute 
amounts of Mfge8 RNA in cultured microglia (purity, >95%), 
although this is the main phagocytic cell type in the CNS 
apoptosis in the CNS, and the role of Mfge8 in the removal 
of apoptotic cells is well established (Hanayama et al., 2002, 
2004; Kranich et al., 2008). If the absence of Mfge8 were to 
impair the removal of prion-infected apoptotic neurons, this 
might contribute to the rise in PrPSc in Mfge8/ mice and 
could explain their shortened incubation time.
Therefore, we determined the prevalence of apoptotic 
cells by terminal transferase dUTP nick end labeling (TUNEL) 
in at least three cerebellar regions of five to seven Mfge8+/+ 
and Mfge8/ mice. The mean frequency of TUNEL+ cells 
per region was normalized against the total number of DAPI+ 
nuclei in each region of interest. We detected an approxi-
mately twofold increase of TUNEL+ cells in cerebelli of ter-
minally sick Mfge8/ mice (P = 0.023; Fig. 2 C). In other 
brain areas, TUNEL+ cells were rare, and no difference was 
detected between Mfge8/ and Mfge8+/+ mice (unpublished 
data). This finding suggests that Mfge8 is involved in the re-
moval of prion-damaged cells in the cerebellum. The paucity 
of apoptotic cells in other areas implies that factors other than 
Mfge8 ensure rapid removal of dead cells there.
Astrocytes express Mfge8
The cellular source of Mfge8 in the CNS is not well charac-
terized. Human and mouse astrocytes, microglia, and smooth 
muscle cells (Boddaert et al., 2007; Fuller and Van Eldik, 
Figure 2. Histopathological analysis of terminal Mfge8/ brains. (A) Astroglia proliferation was analyzed by GFAP staining. (B) Microglial activa-
tion was visualized by IBA1 staining. (C) TUNEL staining on cerebellar cryosection of i.c. inoculated B6.129-Mfge8/ (n = 5) and B6.129-Mfge8+/+ mice  
(n = 7). Sections were counterstained with DAPI. Bar graph shows quantitation of TUNEL+ cells from at least three cerebellar areas per mouse. Number of 
TUNEL+ cells was normalized against the number of DAPI+ nuclei. Graph shows percentage of TUNEL+ cells per area ± SD (*, P = 0.023; Student’s t test). 
Results summarize at least five independent experiments. Bars: (A and C) 100 µm; (B) 200 µm.
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Figure 3. Analysis of the cellular source of Mfge8. (A) ISH for Mfge8 on brain cryosections. Mfge8+ cells (dark purple) were found in cerebellar (top) 
and cortical areas (bottom). Low and high magnification photographs of the same cerebellar (top) and cortical (bottom) areas are shown. Boxes indicate 
areas shown in higher magnifications. The arrow indicates the cell shown in high magnification. (B) Expression of Mfge8 in cultured astrocytes, microglia, 
oligodendrocytes, and neurons was quantified by quantitative RT-PCR. Mfge8 expression in each subset relative to total brain is shown (n = 3). (C) ISH for 
Mfge8 in prion-inoculated Mfge8+/+ mice at terminal stage (left). Right panel shows relative Mfge8 mRNA expression in mock- and RML-inoculated 
brains as assessed by quantitative RT-PCR (n = 3). (D) Quantitative RT-PCR quantitation of Mfge8, Cd11b, and Gfap expression in cerebellar slice cultures 
from untreated CD11b-HSVTK mice (HSVTK), prion-inoculated untreated CD11b-HSVTK mice (HSVTK + RML), GCV-treated CD11b-HSVTK mice (HSVTK + GCV), 
and prion-inoculated GCV-treated CD11b-HSVTK mice (HSVTK + RML + GCV; Student’s t test; n = 4). Uninfected HSVTK + GCV slices compared with  
HSVTK slices have a slight but significant reduction of Mfge8 (***, P = 0.0007). No difference in expression in HSVTK + RML + GCV slices compared with 
HSVTK + RML slices (NS, P = 0.1566). HSVTK + RML slices compared with HSVTK show significant down-regulation (**, P = 0.0082). CD11b expression is 
down-regulated by almost 3 logs in GCV -treated slices, confirming efficient depletion of microglia (HSVTK + GCV: ***, P < 0.0001; HSVTK + RML + GCV: 
***, P < 0.0001). Gfap expression is slightly reduced after GC treatment (HSVTK + GCV: *, P = 0.0255). (E) Analysis of integrin v (Itgav), 3 (Itgb3), and 5 
(Itgb5) expression by quantitative RT-PCR (Student’s t test; n = 4). No significant changes in Itgav expression were found. Itgb3 and Itgb5 were down-
regulated in GCV-treated compared with nontreated slices (Itgb3 HSVTK + GCV: ***, P < 0.0001; Itgb3 HSVTK + RML + GCV: ***, P = 0.0007; Itgb5 HSVTK + 
GCV: ***, P = 0.0002; Itgb5 HSVTK + RML + GCV: ***, P < 0.0001). Error bars represent SD. ISH and quantitative RT-PCR results are shown representative of 
3 and 12 independent experiments, respectively.
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Figure 4. Inoculation of Mfge8/ mice on different genetic backgrounds. (A) Mfge8+/+, Mfge8+/, and Mfge8/ mice on B6.129 (top), C57BL/6 
(middle), and B6.129.Balb/C (bottom) background were inoculated i.c. with 3 log LD50 of RML5 prions (n = 5–9 per group). Significantly accelerated incu-
bation times between Mfge8/ and Mfge8+/+ or Mfge8+/ mice were only seen in B6.129 and B6.129.Balb/C backgrounds (*, P < 0.05; **, P < 0.01; ***,  
P < 0.001). Right panel summarizes the STR analysis of inoculated mice. Pie charts show the percentage of B6 (blue), Balb/C (green), and 129Sv (red) alleles 
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(Fig. 3 B), and the microglial cell line BV-2 was reported to 
express Mfge8 (Fuller and Van Eldik, 2008). Because explanted 
microglia tend to dedifferentiate and to become activated, we 
wondered whether microglia up-regulate Mfge8 expression upon 
activation. Therefore, we performed quantitative RT-PCR and 
ISH on brains of terminally prion-sick mice, which displayed 
an extremely high density of activated microglia. Even here, the 
Mfge8 expression pattern was similar to that of healthy mice 
(Fig. 3 C, left). In fact, the overall amount of Mfge8 RNA was 
slightly reduced in RML-inoculated mice as compared with 
mice inoculated with noninfected brain homogenate (Fig. 3 C, 
right). Combination of immunofluorescence to visualize mi-
croglia using IB4 (isolectin B4) and ISH for Mfge8 failed to 
show colocalization (Fig. S2) of IB4 and Mfge8. These results 
negate a major contribution of microglia to the availability of 
Mfge8 within the CNS, be it in health or in disease.
To further address whether microglia might constitute a 
source of Mfge8, cerebellar slice cultures were prepared from 
CD11b-HSVTK mice (Heppner et al., 2005), from which 
microglia can be depleted by administering ganciclovir (GCV; 
Falsig et al., 2008). The efficiency of depletion was assessed by 
quantitative RT-PCR for CD11b, which is exclusively ex-
pressed in the brain by microglia. CD11b expression was re-
duced by almost 3 logs (Fig. 3 D), confirming that microglia 
were virtually absent after the addition of GCV. Mfge8 expres-
sion was slightly reduced after microglia depletion (Fig. 3 D, 
HSVTK + GCV). This suggests that in organotypic slices, 
which show prodigious levels of microglial activation, some 
Mfge8 may be microglia borne (Falsig et al., 2008). Con-
versely, GCV-treated slices displayed a slight reduction in 
Gfap (Glial fibrillary acidic protein) expression, suggesting that 
astrocytes were also affected by GCV to some degree. Thus, 
the decrease in Mfge8 expression might represent a conse-
quence of marginal astrocyte depletion. Alternatively, the de-
pletion of microglia may quench astrocytic transcription of 
Mfge8 indirectly, e.g., through the depletion of microglia-
borne cytokines. Expression of neuron-specific Nefh (neuro-
filament heavy chain) and oligodendrocyte-specific Mbp (myelin 
basic protein) was not affected by GCV treatment (unpublished 
data). Consistent with the in vivo results (Fig. 3 C, right), we 
also observed a slight reduction of Mfge8 expression in prion-
infected slice cultures (Fig. 3 D, HSVTK + RML). The afore-
mentioned findings support the notion that most or all Mfge8 
present in the CNS is not produced by microglia but rather by 
subsets of astrocytes encompassing cerebellar Bergman glia.
We next analyzed the expression of v3 and v5 integ-
rins in CD11b-HSVTK slices, receptors that were shown to be 
required for Mfge8-dependent engulfment of apoptotic cells 
(Hanayama et al., 2002). Although quantitative RT-PCR 
analysis of the v subunit (Itgav) was unchanged in microglia-
depleted slices, expression of the 3 (Itgb3) and 5 (Itgb5) sub-
unit was decreased by 90% and 75%, respectively (Fig. 3 E). 
Although microglia are not the major source of Mfge8, they 
are the major cell type expressing the Mfge8 receptors v3 
and v5. Thus, our findings strongly suggest that microglia 
are required for removal of apoptotic prion-infected cells.
The influence of Mfge8 on prion pathogenesis is modulated 
by quantitative trait loci
We then tested the reproducibility of the aforementioned find-
ings using RML5 prions (derived from a different passage of the 
same inoculum as RML6) and also repeated the inoculations 
using Mfge8/ mice on a different genetic background. Our 
initial inoculation experiments with RML6 were conducted us-
ing the originally published Mfge8/ strain (Hanayama et al., 
2004) bred on a mixed C57BL/6 × 129Sv background (B6.129-
Mfge8/). This resulted in a 40-d acceleration of the disease. 
Inoculations of B6.129-Mfge8/ with 3 log LD50 of RML5 re-
sulted again in a strongly accelerated incubation time. In the lat-
ter experiment, the mean difference was 20 d (Fig. 4 A, top left) 
and was, again, highly statistically significant (P = 0.0002). The 
variation of the latency between B6.129-Mfge8/ inoculated 
with RML5 and RML6 (Fig. 1 A) is likely to reflect differences 
between the infectivity titers of the two inocula.
When we inoculated Mfge8/ mice that had been back-
crossed to the C57BL/6 background for 10 generations 
(B6-Mfge8/) with 3 log LD50 RML5, we did not observe 
any acceleration of pathogenesis. B6-Mfge8/, B6-Mfge8+/, 
and B6-Mfge8+/+ mice all succumbed to disease after a time 
period of 180 d (Fig. 4 A, middle left). Accordingly, the 
PrPSc levels and the density of apoptotic granule cells were 
not altered in B6-Mfge8/ mice (Fig. S3, A and B). These 
results suggest that the effect of Mfge8 on the course of prion 
infections can be overridden by unidentified genetic modifi-
ers that are polymorphic between the B6 and 129Sv strains. 
To gain more insights into the distribution of these modifi-
ers, we crossed B6.129-Mfge8/ mice to a third genetic 
background (Balb/C). Inoculation of the resulting F2 genera-
tion littermates (B6.129.Balb/C-Mfge8/, -Mfge8+/, and 
-Mfge8+/+) showed that pathogenesis was again accelerated by 
the removal of Mfge8 (Fig. 4 A, bottom left). The variability 
of incubation times was increased, most likely because of the 
increased genetic heterogeneity of the mouse collectives.
To investigate whether differential expression of Mfge8 
or its receptors v3 and v5 integrins might contribute to 
the observed background effect, we analyzed their mRNA 
levels by quantitative RT-PCR on whole brain cDNA from 
B6 and B6.129 Mfge8+/+ mice (Fig. S4 A). Expression levels 
of Mfge8, Itgb3, and Itgb5 were similar in all mice analyzed, 
yet one specific primer pair annealing to the 3 end of the 
per mouse. Each chart represents one mouse. Only alleles that could unambiguously be assigned to one of the three different genetic backgrounds  
are represented in the pie charts. (B) Linear regression analysis comparing incubation time with number of 129Sv alleles. No correlation was seen between 
incubation time and number of 129Sv alleles in Mfge8+/+ and Mfge8+/ mice. However, there was a strong correlation in Mfge8/ mice. Results repre-
sent at least five independent experiments.
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et al., 2008). Mice expressing a mutant TLR4 (Toll-like re-
ceptor 4) defective in intracellular signaling were reported to 
experience accelerated disease after prion inoculation, imply-
ing that absence of TLR4 might impair microglia activation 
and consequently prion clearance. However, there was no 
difference in PrPSc levels at terminal disease stage in this model 
(Spinner et al., 2008). Even in mice engineered to overexpress 
PrPC, which have drastically shortened incubation times, the 
accelerated prion replication does not lead to elevated PrPSc 
levels (Fischer et al., 1996). In contrast, Mfge8/ mice dis-
played enhanced PrPSc deposition despite accelerated disease 
progression. These findings strongly suggest that these mice 
suffer from decreased prion clearance.
Why does the absence of Mfge8 result in elevated levels 
of PrPSc? Upon prion infection, neurons may experience pro-
gressive damage and ultimately undergo apoptosis; during this 
process, they may secrete apoptotic PS-coated bodies con-
taining prions (Ashok and Hegde, 2006; Leblanc et al., 2006). 
We suggest that astrocyte-derived Mfge8 opsonizes these 
prion-laden apoptotic bodies by binding to PS exposed on 
their surface. Microglia, the main phagocytic cell type of the 
CNS, express the Mfge8 receptors, v3 and v5 integrin 
heterodimers. Because microglia antagonize prion replication 
(Falsig et al., 2008), it appears plausible that Mfge8-opsonized, 
prion-laden apoptotic bodies are taken up and degraded 
Itgb3 open reading frame yielded dramatically different quan-
titative RT-PCR reads between the two strains (unpublished 
data). This idiosyncrasy suggested the existence of polymor-
phisms between the B6 and 129Sv alleles of the Itgb3 gene 
leading to differential annealing and artifactual quantitative 
RT-PCR results. Therefore, we analyzed the microsatellite 
marker D11Mit128, which is located within 1 cM from the 
Itgb3 locus and discriminates between B6 and 129Sv allelo-
types, in prion-inoculated mice (Fig. S4 B). We found that 
only Mfge8/ mice homozygous for the 129Sv allele of 
D11Mit128 showed accelerated prion pathogenesis (Fig. S4 B, 
red box plots). Whenever a B6 allele of D11Mit128 was pres-
ent, the presence or absence of Mfge8 failed to alter the incu-
bation time (Fig. S4 B, blue and green box plots).
These results suggest that Mfge8/v3 integrin–dependent 
phagocytosis is affected by strain-specific Itgb3 allotypes. 
Therefore, we sequenced the open reading frame of Itgb3 of 
129Sv, C57BL/6, and Balb/C Mfge8+/+ mice. We found sev-
eral strain-specific single nucleotide polymorphisms, yet none 
of these resulted in codon changes (Fig. S4 C). Thus, the link-
age to D11Mit128 may point to noncoding polymorphisms 
that may affect splicing, mRNA stability, or posttranscrip-
tional control by microRNAs.
We then performed a whole genome linkage analysis of 
all inoculated mice with 209 short tandem repeats (STRs; 
mean genetic distance, 7 cM; 13.5 Mbp) polymorphic be-
tween B6, 129Sv, or Balb/C mice (Table S1). Alleles that 
were shared by two different mouse strains were counted sepa-
rately (B6 + 129Sv, B6 + Balb/C, or 129Sv + Balb/C), and 
all remaining alleles were regarded as noninformative (Table I). 
The percentages of B6 (blue), Balb/C (green), and 129Sv 
(red) alleles were summarized in pie charts (Fig. 4 A, right). 
Analysis of covariance was performed to analyze the inde-
pendent effects of Mfge8 deficiency and genetic background 
on incubation time. In crossbred mice, the Mfge8 genotype 
significantly correlated with the incubation time of prion dis-
ease, even after elimination of possible genetic confounders 
by adjusting the contribution of each genetic background. 
The number of 129Sv alleles also influenced the incubation 
time (Table I). Linear regression analysis revealed a correla-
tion of the incubation time and the amount of 129Sv alleles 
only in Mfge8/ mice (R2 = 0.86; Fig. 4 B). Therefore, Mfge8 
deficiency accelerates the prion pathogenesis, but only in the 
genetic context of the 129Sv strain.
DISCUSSION
Many factors control incubation times of prion diseases after 
i.p. inoculation, including components of the immune system 
(Mabbott et al., 1998; Aguzzi, 2003), depletion of FDCs 
(Montrasio et al., 2000), and manipulations of the comple-
ment system (Klein et al., 2001; Mabbott et al., 2001). How-
ever, interference with prion replication in the CNS is more 
difficult, and there are only few interventions known to alter 
the incubation time of prion diseases after i.c. inoculation. 
Even fewer factors have been found to accelerate pathogenesis 
after i.c. administration of prions (LaCasse et al., 2008; Spinner 
Table I. Statistical analysis of STR results
Source F P-value
Number of B6 alleles and Mfge8 genotype
Number of B6 alleles 0.4 0.53
Mfge8 genotype 4.2 0.021
Number of 129Sv alleles and Mfge8 genotype
Number of 129Sv alleles 6.3 0.016
Mfge8 genotype 5.6 0.007
Number of Balb/C alleles and Mfge8 genotype
Number Balb/C alleles 0.6 0.44
Mfge8 genotype 4.1 0.023
Number of B6/129Sv alleles and Mfge8 genotype
Number of B6/129Sv alleles 5.7 0.022
Mfge8 genotype 5.3 0.009
Number of B6/Balb/C alleles and Mfge8 genotype
Number of B6/Balb/C alleles 0.3 0.61
Mfge8 deficiency 4.2 0.022
Number of 129Sv/Balb/C alleles and Mfge8 genotype
Number of 129Sv/Balb/C alleles 0.1 0.81
Mfge8 deficiency 4.2 0.022
Number of unknown alleles and Mfge8 genotype
Number of unknown alleles 0.9 0.34
Mfge8 deficiency 3.5 0.039
Summary of results from analysis of covariance for incubation time with Mfge8 
genotype as factor and number of alleles corresponding to the various genetic 
backgrounds as covariates. The between-subjects factors are Mfge8+/+ (n = 16), 
Mfge8+/ (n = 14), and Mfge8/ (n = 16). The dependent variable is incubation 
time. F-values correspond to (1,42) and (2,42) degrees of freedom for the covariates 
and the genotype, respectively.
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RML6). For i.c. inoculations, 30 µl of inoculum with 3 log LD50 units was 
administered. Scrapie was diagnosed according to clinical criteria (ataxia, 
kyphosis, priapism, and hind leg paresis). Mice were sacrificed on the day of 
onset of terminal clinical signs of scrapie.
Histoblot, Western blot, ELISA, histology, TUNEL assay, and ISH. 
Detection of splenic PrPSc accumulation by histoblot (Taraboulos et al., 
1992), detection of PrPC and PrPSc by Western blot (Lau et al., 2007), and 
quantitation of PrPC by sandwich ELISA (Polymenidou et al., 2008) were 
performed as described previously.
Immunohistochemistry for SAF84 (1:200), GFAP (1:1,000), and IBA1 
(1:1,000) was performed on paraffin sections and detected with diamino-
benzidine (Sigma-Aldrich). Tissue was treated with formic acid to inactivate 
prion infectivity. Sections were incubated in Ventana buffer, and stains were 
performed on an immunohistochemistry robot (NEXEX; Ventana Instru-
ments) using an IVIEW DAB Detection kit (Ventana Instruments).
TUNEL stainings were performed on cryosections with the ApopTaq 
Plus Fluorescein In Situ Apoptosis Detection kit (Millipore) according to the 
manufacturer’s instructions. ISH using an Mfge8 riboprobe was performed as 
described previously (Kranich et al., 2008). In selected experiments, slides 
were subsequently stained with IB4–Alexa Fluor 647 (Invitrogen) and DAPI 
(Sigma-Aldrich).
MPA. Brain homogenate was diluted in TBS with 0.1% Triton X-100 
and subjected to immunoprecipitation using magnetic beads coupled to 
the peptoid PSR1 (Lau et al., 2007). Samples were incubated 1 h at 37°C 
under permanent agitation and then washed and denatured with 0.1 N 
NaOH. After neutralization (0.3 M Na2H2PO4), samples were placed on 
a magnet, and supernatant was transferred to POM19 (Polymenidou et al., 
2005)-coated ELISA plates. After incubation (1 h at 37°C), plates were 
washed, and POM2-AP (Polymenidou et al., 2005) was added. After in-
cubation with substrate (enhance chemiluminescence; GE Healthcare), 
plates were read in a luminometry reader (Lumiscan Ascent; Thermo 
Fisher Scientific).
SCA. SCA was performed as described previously (Klöhn et al., 2003) with 
minor adaptations. Prion-susceptible neuroblastoma N2aPK1 cells were in-
oculated with Mfge8+/+ and Mfge8/ brain homogenate in 96-well plates for 
3 d. Prion infectivity titers were determined after cells were split three times 
1:3 and three times 1:10. For this, 25,000 cells from each well were filtered 
onto the membrane of an ELISPOT plate, treated with PK, and denatured. 
Individual infected (PrPSc positive) cells were detected by ELISA using the 
anti-PrP antibody POM1 (Polymenidou et al., 2005). The number of TCI 
units per aliquot was calculated from the proportion of negative to total wells 
using the Poisson equation.
Cell-enriched primary cultures. Mixed glia cultures were prepared from 
cerebra of pups (1–2 d postpartum) as previously described (Giulian and 
Baker, 1986). Purity of microglia was determined by staining with IB4 and 
was typically >95%. Purity of oligodendrocyte precursors and astrocytes was 
determined by NG2 and GFAP staining and was found to typically exceed 
85% and 95%, respectively. Cerebellar granule neurons were cultured from 
7-d-old mice as previously published (Leist et al., 1997). Cultures consisted 
of 95% cerebellar granule neurons and <5% astrocytes, as determined by 
staining for III-tubulin and GFAP.
Quantitative RT-PCR. Total RNA from brain or cultured cells was iso-
lated using TRIZOL (Invitrogen) and subjected to cDNA synthesis using 
QuantiTect Reverse Transcription kit (QIAGEN) according to the manu-
facturer’s instruction. Quantitative real-time PCR was performed on a 
7900HT Fast Real-Time PCR system (Applied Biosystems). Expression 
levels were normalized using Gapdh (glyceraldehyde-3-phosphate dehydrogenase).
Gapdh forward (5-CCACCCCAGCAAGGAGACT-3), Gapdh reverse 
(5-GAAATTGTGAGGGAGATGCT-3), Mfge8 forward (5-ATATGGG-
TTTCATGGGCTTG-3), Mfge8 reverse (5-GAGGCTGTAAGCCACC-
TTGA-3), Integrin v forward (5-CACCAGCAGTCAGAGATGGA-3), 
by microglia. Because clearance of apoptotic bodies is in-
efficient in the absence of Mfge8, prions may persist in the 
brain and exacerbate PrPSc accumulation, thereby acceler-
ating the disease.
Whereas the brain concentration of PrPSc was dramati-
cally increased in the absence of Mfge8, prion infectivity 
titers were altered to a much smaller extent. Because prion 
titers are likely to reflect the number of individual PrP aggre-
gates capable of nucleating further PrP, these findings suggest 
that the defective clearance caused by the absence of Mfge8 
allows primarily for the elongation of PrPSc seeds rather than 
for their numerical expansion.
The aforementioned model implies a multitiered control 
of phagocytosis in the brain, whereby astrocytes are the source 
of Mfge8 and microglia are the executioners of phagocytosis. 
In this model, microglia would operate at highest efficiency 
only when armed by astrocyte-borne Mfge8. In the absence 
of the latter, removal of apoptotic cells, and of any prions that 
might be contained therein, would be impaired. We have 
discovered an analogous collaboration in germinal centers of 
lymphoid organs between FDCs and tingible body macro-
phages. There, FDCs produce Mfge8 and thereby license 
tingible body macrophages to engulf apoptotic cells (Kranich 
et al., 2008). In the CNS, an additional level of complexity 
may be added by the finding that astrocytes express markers 
of phagocytic pathways, including the Mfge8 receptor v5 
(Barres, 2008; Cahoy et al., 2008), and may have phagocytic 
potential of their own.
The regulation of phagocytosis is complex, and several inde-
pendent, redundant pathways of phagocytosis are known. Mfge8 
may not be the only mediator of engulfment, and some hitherto 
unidentified factors may, in certain situations, compensate for its 
absence. Strong evidence for the latter scenario comes from our 
observation that the acceleration of prion pathogenesis seen in 
Mfge8/ mice is crucially dependent on the genetic background 
of mice. Although the Mfge8 genotype was the major determi-
nant of incubation time, one or more additional loci (potentially 
including the Mfge8 receptors) act as important modifiers. Be-
cause these loci appear to be polymorphic between the 129Sv 
and the C57BL/6 strains of mice, it may be possible to identify 
them through larger-scale analyses of prion pathogenesis in F2 
crosses between said mouse strains.
MATERIALS AND METHODS
Mice. Mfge8/ mice were donated by S. Nagata (Graduate School of Med-
icine, Kyoto University, Sakyo-ku, Kyoto, Japan) and were on a mixed 
(C57BL/6 × 129Sv)F1 (Hanayama et al., 2004) or C57BL/6 background. 
B6.129.Balb/C-Mfge8/ mice were generated in our facility by intercross-
ing B6.129-Mfge8/ mice with Balb/C mice (Harlan Laboratories). As con-
trols, C57BL/6 (Harlan Laboratories) or F1 offsprings of crossings between 
C57BL/6 and 129Sv mice (Charles River) were used. For microglia deple-
tion experiments, CD11b-HSVTK mice were used (Heppner et al., 2005). 
All experiments were performed in accordance with Swiss federal legislation 
and were approved by the Veterinäramt des Kantons Zurich (Veterinary office 
of the Canton Zurich).
Inoculations. Mice were inoculated i.p. with 100 µl of brain homogenate 
diluted in PBS with 5% BSA and containing 3 log LD50 units of the Rocky 
Mountain Laboratories scrapie strain (passage 5 and 6, thus called RML5 and 
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